Paragon Capital Management (Kansas)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-166
Closed -$12K 122
2020
Q1
$12K Buy
+166
New +$13K 0.01% 133
2019
Q3
Sell
-105
Closed -$8K 156
2019
Q2
$8K Sell
105
-122
-54% -$9.34K ﹤0.01% 169
2019
Q1
$18K Buy
+227
New +$17K 0.01% 134

Other funds holding MRK

Paragon Capital Management (Kansas)'s MRK Position: Q2 2020 in Review

Paragon Capital Management (Kansas) sold out of Merck (MRK) in Q2 2020, closing a stake of 166 shares — an estimated $12K sold.

Paragon Capital Management (Kansas) first reported a position in MRK in Q1 2019 and held it in 3 quarters. The position peaked at $18K in Q1 2019. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • Paragon Capital Management (Kansas) reported no remaining Merck position as of Q2 2020 after selling out during the quarter.
  • Paragon Capital Management (Kansas) sold 166 Merck shares in Q2 2020, an estimated $12K.
  • Paragon Capital Management (Kansas) first reported a position in Merck in Q1 2019 and held it in 3 quarters.
  • Paragon Capital Management (Kansas)'s Merck position peaked at $18K in Q1 2019.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q2 2020, filed 3 Aug 2020.